Down ‐regulated SHARPIN may accelerate the development of atopic dermatitis through activating interleukin‐33/ST2 signaling

Experimental Dermatology,Volume 0, Issue ja, -Not available-.
Source: Experimental Dermatology - Category: Dermatology Authors: Source Type: research
More News: Dermatitis | Dermatology | Skin